Alpha(1)-adrenoceptor antagonists have also been shown to improve hepatic microvascular dysfunction by significantly reducing hepatic erythrocyte accumulation, thereby effectively alleviating APAP-induced liver injury
And your conclusions are built on a faulty premise
These neuropathies manifest with symptoms that start in the hands and progressively involve both the lower and upper limbs, indicating potential myelopathy [79, 80]
Preclinical and clinical data, though predominantly derived from case reports and small cohort studies to date, consistently indicate that GLP-1 RAs - including liraglutide, semaglutide, and the dual GIP/GLP-1 RA tirzepatide - can induce clinically meaningful weight loss, suppress the characteristic severe hyperphagia, and improve key cardiometabolic parameters in both heterozygous and homozygous MC4R variant carriers
Microdosing isnt a magic bullet
Even the ingredients they may contain have limited evidence when they are taken orally